绝经后女性冠心病相关危险因素的研究进展
Research Progress on Risk Factors of Coronary Heart Disease in Postmenopausal Women
DOI: 10.12677/ACM.2023.13122768, PDF,   
作者: 张笑玮, 木胡牙提：新疆医科大学第一附属医院心脏中心综合心脏内科，新疆 乌鲁木齐
关键词: 绝经后女性；冠心病；危险因素；激素替代治疗；Postmenopausal Women； Coronary Heart Disease； Risk Factor； Hormone Replacement Therapy
摘要: 冠状动脉粥样硬化性心脏病(简称冠心病)是临床常见的心血管疾病，近年来发病率和死亡率均在持续上升。绝经后女性是一类特殊人群，有研究发现绝经后女性冠心病有其自身的发病特点，本综述通过系统文献回顾的方式，对绝经后女性冠心病的临床特点及临床危险因素进行综合研究及整理，系统阐述绝经后女性的危险因素及特殊治疗方式。
Abstract: Coronary atherosclerotic heart disease (CHD) is a common clinical cardiovascular disease, and its morbidity and mortality have been increasing in recent years. Postmenopausal women are a special group of people, and some studies have found that postmenopausal women with coronary heart disease have their own characteristics. Through systematic literature review, this paper compre-hensively studied and sorted out the clinical characteristics and clinical risk factors of coronary heart disease in postmenopausal women, and systematically expounded the risk factors and special treatment methods of postmenopausal women.
文章引用：张笑玮, 木胡牙提. 绝经后女性冠心病相关危险因素的研究进展[J]. 临床医学进展, 2023, 13(12): 19668-19672. https://doi.org/10.12677/ACM.2023.13122768

参考文献

[1] Kitagawa, T., Yamamoto, H., Sentani, K., et al. (2015) The Relationship between Inflammation and Neoangiogenesis of Epicardial Adipose Tissue and Coronary Atherosclerosis Based on Computed Tomography Analysis. Atherosclerosis, 243, 293-299. [Google Scholar] [CrossRef] [PubMed]
[2] 康俊玲, 赵淑萍, 赵丽萌, 等. 围绝经期女性雌激素水平变化与冠心病发生的相关性分析[J]. 中国实用医药, 2022, 17(25): 106-108.
[3] 姚远, 高航. 女性绝经后冠心病患者心功能状况及血浆雌二醇、N端前脑钠肽水平分析[J]. 中国妇幼保健, 2018, 33(8): 1808-1811.
[4] 吴燕, 李晓微, 冯朝辉, 等. 绝经后女性甲状腺激素水平与冠状动脉粥样硬化相关性的研究进展[J]. 中国实验诊断学, 2017, 21(10): 1856-1859.
[5] 冯静茹, 张海洋, 史贺, 等. 绝经后急性冠脉综合征患者雌激素与超敏C反应蛋白、NT-proBNP相关性研究[J]. 河北北方学院学报(自然科学版), 2023, 39(4): 6-10.
[6] 夏梦远, 徐涛良, 倪润泽, 等. C反应蛋白与白蛋白比值和中性粒细胞与淋巴细胞比值与绝经后女性冠状动脉病变的相关性分析[J]. 中国心血管病研究, 2023, 21(5): 390-396.
[7] 帅维, 王辉波. 妊娠次数与绝经后女性冠心病的相关性分析[J]. 巴楚医学, 2019, 2(4): 8-11, 24.
[8] 王冰冰, 温烨莹, 杨乐, 等. 睡眠时长和睡眠质量与冠心病患病的关联性[J]. 福建医科大学学报, 2023, 57(1): 16-21.
[9] 闻伟, 叶青, 张理想, 等. 老年绝经女性冠心病发生风险的列线图预测模型的构建及验证研究[J]. 临床心血管病杂志, 2022, 38(7): 541-548.
[10] 颜益新. 冠心病患者血清多不饱和脂肪酸和CXCL12水平变化及与冠状动脉病变程度的相关性分析[J]. 心血管病防治知识, 2023, 13(17): 37-39.
[11] 周玉丽, 徐金锋, 刘莹莹. 趋化因子CCL5及其受体CCR5在乳腺癌中作用的研究进展[J]. 肿瘤, 2015, 35(8): 920-925.
[12] 钱芳, 李华, 瞿秋红, 等. 绝经后女性冠心病患者趋化因子CCL5水平与冠状动脉病变程度的相关性[J]. 数理医药学杂志, 2018, 31(6): 822-824.
[13] 邱梓峰, 卢宇轩, 孙永安, 等. 高同型半胱氨酸血症对缺血性脑卒中影响的研究进展[J]. 中华老年心脑血管病杂志, 2023, 25(8): 879-881.
[14] Liu, Y., Wang, X., Wang, T., et al. (2022) Relationship between Coronary VH-IVUS Plaque Characteristics and CTRP9, SAA, and Hcy in Patients with Coronary Heart Disease. Journal of Healthcare Engineering, 2022, Article ID: 1635446. [Google Scholar] [CrossRef] [PubMed]
[15] 符少萍, 陈焕清, 陈玉成, 等. 雌激素与同型半胱氨酸对绝经期女性冠心病的影响和相关性分析[J]. 现代医学与健康研究电子杂志, 2022, 6(23): 21-23.
[16] 廖丽萍, 周跟东, 张晓红, 等. 淋巴单核细胞比值与老年绝经后女性冠心病的相关性分析[J]. 中华老年心脑血管病杂志, 2021, 23(11): 1158-1161.
[17] Moroni, F., Ammirati, E., Norata, G.D., et al. (2019) The Role of Monocytes and Macrophag-es in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis. Mediators of Inflammation, 2019, Article ID: 7434376. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, L., Ma, X. and Wang, W. (2020) Inflammation and Coronary Heart Disease Risk in Patients with Depression in China Mainland: A Cross-Sectional Study. Neuropsychiatric Disease and Treatment, 16, 81-86. [Google Scholar] [CrossRef] 
[19] Xu, R., Li, Y.Y., Ma, L.L., et al. (2020) Association of Vitamin D Status with Coronary Artery Disease in Postmenopausal Women. Medicine, 99, e19544. [Google Scholar] [CrossRef] 
[20] Mazhar, Z., Hughes, A. and Garelnabi, M. (2017) Targeting the Role of Lipoprotein (a) in Stroke. Cardiovascular & Hematological Disorders-Drug Targets, 17, 64-72. [Google Scholar] [CrossRef] 
[21] Schmidt, K., Noureen, A., Kronenberg, F. and Uter-mann, G. (2016) Structure, Function, and Genetics of Lipoprotein (a). Journal of Lipid Research, 57, 1339-1359. [Google Scholar] [CrossRef] 
[22] 孟杰杰, 刘东升, 白春兰, 等. 血清脂蛋白(a)水平与绝经后女性新发冠心病及其严重程度的相关性研究[J]. 中国心血管杂志, 2021, 26(6): 540-544.
[23] Lobo, R.A. (2017) Hor-mone-Replacement Therapy: Current Thinking. Nature Reviews Endocrinology, 13, 220-231. [Google Scholar] [CrossRef] [PubMed]
[24] Schneider, L.S., Farlow, M.R., Henderson, V.W., et al. (1996) Ef-fects of Estrogen Replacement Therapy on Response to Tacrine in Patients with Alzheimer’s Disease. Neurology, 46, 1580-1584. [Google Scholar] [CrossRef] 
[25] Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al. (2002) Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288, 321-333. [Google Scholar] [CrossRef] [PubMed]
[26] 陈莉, 马晓娟, 史大卓. 激素替代疗法: 获益还是风险[J]. 中西医结合心脑血管病杂志, 2022, 20(11): 2012-2016.
[27] 谢梅青, 陈蓉, 任慕兰. 中国绝经管理与绝经激素治疗指南(2018) [J]. 协和医学杂志, 2018, 9(6): 512-525.

为你推荐